Last Updated:
Name Designation Appointment Date Status
Shyam Bhalchandra Dhawan

Appointed as Director since January 2009

Director 29-Jan-2009 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Girish Nathuram Kolwankar

Appointed as Director since January 2009

Director 29-Jan-2009 Current

People Timeline

Explore the timeline of key personnel in Premium Serums And Vaccines Private Limited's leadership journey.

Loading...
Contact Details
  • Address 406, B Wing,Highway Rose Co-Op Hsg Society 92, Dixit Road Extn.,Vile Parle (East), Mumbai Maharashtra, 400057, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Premium Serums And Vaccines Private Limited?
You can contact Premium Serums And Vaccines Private Limited through their registered address at 406, B Wing,Highway Rose Co-Op Hsg Society 92, Dixit Road Extn.,Vile Parle (East), Mumbai Maharashtra, 400057, India, or via their website at premiumserums.com. Social media links are also provided where applicable.
Who are the current directors of Premium Serums And Vaccines Private Limited?
The current directors of Premium Serums And Vaccines Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SHYAM BHALCHANDRA DHAWAN
  • GIRISH NATHURAM KOLWANKAR
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available